Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis fro...
Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis from the EPHESUS trial
About this item
Full title
Author / Creator
Publisher
New York: Wiley Periodicals, Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York: Wiley Periodicals, Inc
Subjects
More information
Scope and Contents
Contents
Background
Trials using mineralocorticoid receptor antagonists (MRAs) in myocardial infraction (MI) without heart failure (HF) or systolic impairment have been underpowered to assess morbidity‐mortality benefit. In EPHESUS 6632 patients were included, of whom 11% had an ejection fraction (EF) of 40% and HF or diabetes. We aim to assess the poten...
Alternative Titles
Full title
Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis from the EPHESUS trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6837025
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6837025
Other Identifiers
ISSN
0160-9289
E-ISSN
1932-8737
DOI
10.1002/clc.23261
